
Bay willow, black willow, white willow
Willow bark has been used for thousands of years in China and Europe as a remedy for fevers, pain and inflammation. It contains salicin, the phytotherapeutic precursor of aspirin (acetylsalicylic acid).
Willow bark extracts exert anti-inflammatory (1), antiplatelet (2) and antiproliferative (3) effects in vitro. Clinical studies demonstrate their efficacy in the management of back pain (4), osteoarthritis (5), gonarthrosis and coxarthrosis (6). A systematic review suggests it may also be effective in treating low back pain (7).
Topical application of salicin may help reduce aging of the skin (9).
Conclusions of a meta analysis support use of aspirin as a preventative in patients at increased risk of occlusive vascular events, including those with an acute myocardial infarction or ischemic stroke, angina, previous myocardial infarction, stroke, peripheral arterial disease or atrial fibrillation (8).
In 1985, the United States Food and Drug Administration approved aspirin for the treatment and secondary prevention of acute myocardial infarction.
Recent data from epidemiologic and observational studies suggest that aspirin has clinically relevant anticancer effects (10) (11). However, it is not known if willow bark has the same effects.
Because willow bark supplements can have additive effects with non steroidal anti-inflammatory drugs, they should not be given concurrently. Children should not be given willow bark because of the potential for developing Reye syndrome, a serious condition associated with the use of aspirin.
Willow bark extracts demonstrate anti-inflammatory effects that were shown to be due to inhibition of pro-inflammatory cytokines (tumor necrosis factor-alpha), cyclo-oxygenase (COX-2) and nuclear translocation of the transcription factor NF-κB (1). The active compound has been identified as salicin (19). But another study showed involvement of catechol as well in the anti-inflammatory activity along with salicin and flavonoids (13).
Willow bark extract was also found to raise the levels of GSH (reduced glutathione) significantly, an effect that helps to limit lipid peroxidation (14).
The antiproliferative effects of willow bark extracts on human colon and lung cancer cells are due to their growth-inhibitory and apoptosis-inducing properties (15).
Aspirin was shown to overcome tumor resistance and enhance the effectiveness of interferon-alpha against hepatocellular carcinoma by activating the STAT1 gene (16).
Warfarin: When used concurrently, willow bark may increase the risk of bleeding (18).
Beer AM, Wegener T. Willow bark extract (Salicis cortex) for gonarthrosis and coxarthrosis - Results of a cohort study with a control group. Phytomedicine. 2008 Nov;15(11):907-13.
In this open, multi-centric study, 88 patients, ages between 50 and 75, with gonarthrosis and coxarthrosis were treated with a standardized willow bark extract, and 40 patients with standard therapy. Effectiveness of the treatments was determined by clinical findings, recording of adverse events, global tolerance and by patient assessment (WOMAC questions concerning pain and stiffness, questions on general state of health). At 6 weeks from the initiation of the study, researchers reported that the willow bark extract was superior to conventional therapy. It was well tolerated with no adverse effects.
Bottom Line: Willow bark is useful in relieving muscle and joint pain.
Willow bark is commonly used to treat pain and reduce fevers. It contains a compound called salicin that has been shown to have anti-inflammatory effects. Aspirin is the synthetic form of acetylsalicylic acid, which is derived from salicin. Several studies have shown that willow bark extracts are effective in reducing back pain and osteoarthritis. Long term use of low-dose aspirin has been shown to prevent heart attacks.
Observational studies suggest that aspirin may help in lowering the risk of some cancers. It is not known if willow bark supplements will have the same effects.
Gonarthrosis
In this open, multi-centric study, 88 patients, ages between 50 and 75, with gonarthrosis and coxarthrosis were treated with a standardized willow bark extract, and 40 patients with standard therapy. Effectiveness of the treatments was determined by clinical findings, recording of adverse events, global tolerance and by patient assessment (WOMAC questions concerning pain and stiffness, questions on general state of health). After 6 weeks, researchers reported that the willow bark extract was better than conventional therapy. It was also well tolerated with no adverse effects.